Haiwei Mou

Haiwei Mou

Auto-generated profile, based on publicly available information

Haiwei Mou

Melanoma Research Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2017 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
HYHao Yin
Hao Yin
CSChun-Qing Song
Chun-Qing Song
SSSneha Suresh
Sneha Suresh
QWQiongqiong Wu
Qiongqiong Wu
SWStephen Walsh
Stephen Walsh
DADaniel G Anderson
Daniel G Anderson

1 July 2015 in Human Gene Therapy
Verified
Journal Article
Closed access
DWDan Wang
Dan Wang
HMHaiwei Mou
Haiwei Mou
SLShaoyong Li
Shaoyong Li
YLYingxiang Li
Yingxiang Li
SHSoren Hough
Soren Hough
WXWen Xue
Wen Xue
CRISPR/Cas9 derived from the bacterial adaptive immunity pathway is a powerful tool for genome editing, but the safety profiles of in vivo delivered Cas9 (including host immune responses to the bacterial Cas9 protein) have not been comprehensively investigated in model organisms. Nonalcoholic steatohepatitis (NASH) is a prevalent human liver disease characterized by excessive fat accumulation in the liver. In this study, we used adenovirus (Ad) vector to deliver a Streptococcus pyogenes–derived Cas9 system (SpCas9) targeting Pten, a gene involved in NASH and a negative regulator of the PI3K-AKT pathway, in mouse liver. We found that the Ad vector mediated efficient Pten gene editing even in the presence of typical Ad vector-associated immunotoxicity in the liver. Four months after vector infusion, mice receiving the Pten gene-editing Ad vector showed massive hepatomegaly and features of NASH, consistent with the phenotypes following Cre-loxP-induced Pten deficiency in mouse liver. We also detected induction of humoral immunity against SpCas9 and the potential presence of an SpCas9-specific cellular immune response. Our findings provide a strategy to model human liver diseases in mice and highlight the importance considering Cas9-specific immune responses in future translational studies involving in vivo delivery of CRISPR/Cas9.

14 June 2017 in Genome Biology
Verified
Journal Article
Open access
PDF file
HMHaiwei Mou
Haiwei Mou
JSJordan Smith
Jordan Smith
LPLingtao Peng
Lingtao Peng
HYHao Yin
Hao Yin
JMJill Moore
Jill Moore
WXWen Xue
Wen Xue
CRISPR is widely used to disrupt gene function by inducing small insertions and deletions. Here, we show that some single-guide RNAs (sgRNAs) can induce exon skipping or large genomic deletions that delete exons. For example, CRISPR-mediated editing of β-catenin exon 3, which encodes an autoinhibitory domain, induces partial skipping of the in-frame exon and nuclear accumulation of β-catenin. A single sgRNA can induce small insertions or deletions that partially alter splicing or unexpected larger deletions that remove exons. Exon skipping adds to the unexpected outcomes that must be accounted for, and perhaps taken advantage of, in CRISPR experiments.

1 June 2015 in Molecular Cell
Verified
Journal Article
Closed access
EHEmilie Hangen
Emilie Hangen
OFOlivier Féraud
Olivier Féraud
SLSylvie Lachkar
Sylvie Lachkar
HMHaiwei Mou
Haiwei Mou
NDNunzianna Doti
Nunzianna Doti
NMNazanine Modjtahedi
Nazanine Modjtahedi

17 August 2010 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
XLXiaofeng Lu
Xiaofeng Lu
LMLili Ma
Lili Ma
LRLingfei Ruan
Lingfei Ruan
YKYan Kong
Yan Kong
HMHaiwei Mou
Haiwei Mou
LLLe Le
Le Le
Background: Inflammatory responses in the CNS mediated by activated glial cells play an important role in host-defense but are also involved in the development of neurodegenerative diseases. Resveratrol is a natural polyphenolic compound that has cardioprotective, anticancer and anti-inflammatory properties. We investigated the capacity of resveratrol to protect microglia and astrocyte from inflammatory insults and explored mechanisms underlying different inhibitory effects of resveratrol on microglia and astrocytes. Methods: A murine microglia cell line (N9), primary microglia, or astrocytes were stimulated by LPS with or without different concentrations of resveratrol. The expression and release of proinflammatory cytokines (TNF-α, IL-1β, IL-6, MCP-1) and iNOS/NO by the cells were measured by PCR/real-time PCR and ELISA, respectively. The phosphorylation of the MAP kinase superfamily was analyzed by western blotting, and activation of NF-κB and AP-1 was measured by luciferase reporter assay and/or electrophoretic mobility shift assay. Results: We found that LPS stimulated the expression of TNF-α, IL-1β, IL-6, MCP-1 and iNOS in murine microglia and astrocytes in which MAP kinases, NF-κB and AP-1 were differentially involved. Resveratrol inhibited LPS-induced expression and release of TNF-α, IL-6, MCP-1, and iNOS/NO in both cell types with more potency in microglia, and inhibited LPS-induced expression of IL-1β in microglia but not astrocytes. Resveratrol had no effect on LPS-stimulated phosphorylation of ERK1/2 and p38 in microglia and astrocytes, but slightly inhibited LPS-stimulated phosphorylation of JNK in astrocytes. Resveratrol inhibited LPS-induced NF-κB activation in both cell types, but inhibited AP-1 activation only in microglia. Conclusion: These results suggest that murine microglia and astrocytes produce proinflammatory cytokines and NO in response to LPS in a similar pattern with some differences in signaling molecules involved, and further suggest that resveratrol exerts anti-inflammatory effects in microglia and astrocytes by inhibiting different proinflammatory cytokines and key signaling molecules.

1 July 2017 in Cancer Cell
Verified
Journal Article
Closed access
HDHien Dang
Hien Dang
ATAtsushi Takai
Atsushi Takai
MFMarshonna Forgues
Marshonna Forgues
YPYotsowat Pomyen
Yotsowat Pomyen
HMHaiwei Mou
Haiwei Mou
XWXin Wei Wang
Xin Wei Wang